Legend Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $160,205 | $186,523 | $93,991 | $79,464 |
Gross Profit | 104,736 | 136,072 | 33,530 | 41,663 |
EBITDA | -109,910 | -7,117 | -48,591 | -135,641 |
EBIT | -115,382 | -12,486 | -54,313 | -140,992 |
Net Income | -125,321 | -18,196 | -59,793 | -144,818 |
Net Change In Cash | 160,205 | 186,523 | 93,991 | 79,464 |
Free Cash Flow | -77,887 | -5,068 | -6,605 | -118,651 |
Cash | 459,277 | 201,684 | 897,930 | 1,278,070 |
Basic Shares | 183,271 | 182,602 | 182,005 | 181,911 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $285,143 | $117,005 | $89,792 | $75,676 |
Gross Profit | 140,929 | 51,642 | -223,554 | -156,484 |
EBITDA | -477,873 | -416,536 | -392,379 | -294,143 |
EBIT | -498,324 | -434,928 | -406,296 | -304,076 |
Net Income | -518,254 | -446,349 | -386,209 | -303,477 |
Net Change In Cash | 285,143 | 117,005 | 89,792 | 75,676 |
Free Cash Flow | -415,998 | -222,304 | -245,577 | -272,781 |
Cash | 1,277,713 | 786,031 | 688,938 | 455,689 |
Basic Shares | 176,082 | 159,041 | 140,851 | 118,152 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.68 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.80 |
